Methotrexate slows rheumatoid arthritis by reducing the overactive immune response that attacks your joints, which relieves pain and swelling and prevents long-term joint damage. It’s the most widely prescribed first-line treatment for RA and belongs to a class called disease-modifying antirheumatic drugs, meaning it doesn’t just mask symptoms but actually changes the course of the disease. Most people start at a low weekly dose and can expect to notice improvements within about 12 weeks.
How It Calms Joint Inflammation
Methotrexate was originally developed as a cancer drug at extremely high doses (up to 1 gram per dose). At the much lower doses used for RA, typically 15 to 25 mg once a week, it works through a different pathway. The drug increases levels of a molecule called adenosine outside your cells. When adenosine binds to receptors on immune cells, it triggers a cascade that dials down inflammation throughout the body.
It also interferes with the folate pathway, which cells need to divide and function normally. By disrupting this pathway in overactive immune cells, methotrexate reduces the production of inflammatory signals that drive joint swelling, pain, and stiffness. This is why you’ll be prescribed folic acid alongside it: to replenish folate in healthy cells while the drug does its work on the immune system.
Protecting Your Joints From Permanent Damage
Beyond symptom relief, methotrexate’s most important job is preventing the bone erosion and joint space narrowing that make RA progressively disabling. In a five-year trial, half of patients treated with methotrexate showed no radiographic progression at all, and some achieved full clinical remission. Another study calculated that methotrexate slowed the rate of joint destruction by a factor of three compared to the disease’s natural course. This protective effect is the main reason rheumatologists push to start treatment early, even before symptoms feel severe. Joint damage that’s already occurred can’t be reversed, so the goal is to prevent it from happening in the first place.
When methotrexate alone isn’t enough, biologic medications can be added on top of it. Research consistently shows that biologics work better when combined with methotrexate than when used alone.
What to Expect in the First Few Months
The standard starting dose is 7.5 mg taken orally once a week, then gradually increased until you reach an effective dose. Doctors generally keep the dose at or below 20 mg per week, since higher amounts raise the risk of serious side effects without proportional benefit. It can take up to 12 weeks at your full dose before you notice meaningful improvement in joint pain, stiffness, and swelling. This lag is one of the most frustrating parts of treatment, but it’s normal. The drug is working at a cellular level before the effects become obvious.
If oral tablets cause stomach problems or aren’t effective enough, your doctor may switch you to subcutaneous injections (a small shot you give yourself, similar to insulin). Injectable methotrexate gets absorbed more predictably and reaches higher levels in your blood. Oral methotrexate tops out at about 70% absorption and hits a ceiling at 15 mg per week, while the injectable form bypasses the gut entirely. That said, gastrointestinal side effects are roughly similar between the two forms in the first few months of treatment, with about 20 to 30% of patients reporting some stomach issues either way.
Common Side Effects and Folic Acid
The most frequent complaints are nausea, fatigue, and mouth sores. Less commonly, methotrexate can affect liver enzymes or blood cell counts. Taking folic acid alongside your weekly dose significantly reduces these problems. The standard recommendation from the British Society for Rheumatology is at least 5 mg of folic acid once a week, taken on a different day than your methotrexate. Some doctors prescribe 1 mg daily (skipping methotrexate day) instead. In a year-long controlled study, daily folic acid supplementation reduced treatment discontinuation caused by mouth ulcers, nausea, vomiting, and low white blood cell counts.
You’ll need regular blood tests to catch any problems early. The standard monitoring schedule involves checking your blood counts, liver enzymes, and kidney function within the first one to two months after starting, then every three to four months for as long as you take the medication. These tests are routine and straightforward, but they’re not optional.
Alcohol and Other Restrictions
Because methotrexate is processed by the liver, alcohol guidelines come up immediately. The American College of Rheumatology’s older (1994) guidelines recommend near-total abstinence, but more recent evidence paints a more nuanced picture. A large study of RA patients on methotrexate found that drinking fewer than 14 units of alcohol per week (roughly seven standard drinks in the US) carried less than a 1% probability of a clinically meaningful increase in liver enzyme problems. Drinking above 21 units per week, however, nearly doubled the risk. Moderate, occasional drinking appears to be low-risk for most patients, but heavy drinking is clearly harmful.
Who Should Not Take Methotrexate
Methotrexate is strictly off-limits during pregnancy. It’s classified as category X, meaning it causes fetal harm and can cause fetal death. If you’re planning to become pregnant, you’ll need to stop methotrexate well in advance and discuss timing with your rheumatologist. Breastfeeding is also contraindicated, as the drug passes into breast milk.
People with chronic liver disease, cirrhosis, alcoholic hepatitis, or active alcohol use disorder should not take methotrexate for RA. It’s also not recommended for people with significant kidney dysfunction or certain blood disorders, since the drug affects blood cell production and is cleared through the kidneys. Your doctor will check baseline blood work and liver function before prescribing it to rule out these issues.